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Changes in the diagnosed incidence of early
onset schizophrenia over four decades
Introduction
The age at onset of schizophrenia varies, but most
are diagnosed in late adolescence or early adult-
hood (1). The proportion of patients diagnosed
Okkels N, Vernal DL, Jensen SOW, McGrath JJ, Nielsen RE. Changes
in the diagnosed incidence of early onset schizophrenia over four
decades.
Objective: To explore changes in the diagnosed incidence of early
onset schizophrenia (EOS) from 1971 to 2010.
Method: Examination of incidence rates of schizophrenia in patients
under 18 years of age, using a nationwide, population-based, mental
health register.
Results: The age-standardized incidence rate (IR) of EOS in the period
1971–2010 was 3.17 (95% CI: 3.16, 3.18) per 100 000 person years in
the age group 0–18 years, and 9.10 (95% CI: 9.00, 9.21) in the age
group 12–18 years. In the period 1971–1993, the age-standardized IR
of EOS was 1.80 (95% CI: 1.79, 1.82) per 100 000 person years in the
age group 0–18 years, and 5.02 (95% CI: 4.92, 5.11) in the age group
12–18 years. In the period 1994–2010, the age-standardized IR of EOS
was 5.15 (95% CI: 5.10, 5.20) per 100 000 person years in the age group
0–18 years, and 15.73 (95% CI: 15.22, 16.22) in the age group 12–18
years. The IR was higher for males than females in the periods 1971–
1993 and 1971–2010, but in the period 1994–2010 the IR was higher for
females than males.
Conclusion: In recent years, the diagnosed incidence of EOS has
increased and the usual male excess has disappeared. The changes in IR
could be a result of changes in the diagnostic system, increased
awareness of early psychosis or a reflection of actual underlying
incidence of the disorder.
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Significant outcomes
• In the period 1971-2010, the diagnosed incidence of early onset schizophrenia was 3.17 per 100 000
person years.
• The diagnosed incidence of early onset schizophrenia has increased in recent years.
• The usual male excess found in schizophrenia epidemiology is less apparent in recent years in those
with early onset schizophrenia.
Limitations
• Register-based studies may miss individuals who do not have contact with mental health services.
• The validity of early onset schizophrenia diagnoses based on mental health register has not been
tested.
• The reasons behind the changes in diagnosed incidence of early onset schizophrenia cannot
be determined in this study.
Please also see editorial comment by Kelly K. Anderson (Acta
Psychiatr Scand 2013;127:9–10).
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before the age of 18 years, known as early onset
schizophrenia (EOS), is less than five per cent of all
first diagnoses of schizophrenia (2–4). The inci-
dence of EOS is of interest for several reasons.
First, studies suggest that those with EOS have
prominent delays in speech, language and motor
development, poorer general psychopathology and
poorer long-term outcome compared with adult
onset schizophrenia (5). As a consequence of this,
there has been considerable interest in optimizing
the early identification of psychosis (6, 7) and in the
development of specialized services for treatment
of psychosis in teenagers and young adults (7–9).
Second, there is a need to monitor secular changes
in incidence rates of psychoses, in order to evaluate
how the increased attention to early psychosis
impacts on limited health resources (10, 11). Third,
from an epidemiological perspective, changes in
incidence rates can provide important clues to
underlying etiological factors (12).
Changes in incidence of schizophrenia have been
studied extensively, but mostly in adults (13–19).
The studies report both increases and decreases in
incidence (16–18, 20–23). Studies on patients diag-
nosed before the age of 18 years are sparse.
Current Danish data show an increase in the
incidence of hospitalization of EOS in the time
period 1994–2006 (3). To our knowledge, no other
large-scale studies have been conducted on the
incidence of EOS over longer time periods.
Aims of the study
To investigate the incidence of schizophrenia in the
age group 0 to 18 years from 1971 to 2010.
Material and methods
Design
We conducted a register-based study of EOS
covering the period from January 1st 1971 to
December 31st 2010. All incidence measures
described are incidences of diagnosed disorder,
implying that an unknown proportion of persons
fulfilling the diagnostic criteria were not diagnosed
and therefore not included. The term incidence is
used as a substitute for diagnosed incidence
throughout the paper.
Sample
Cases were selected from the Danish Psychiatric
Central Research Register (DPCRR), which
includes data from all admissions to psychiatric
hospitals in Denmark since 1969 (24, 25). However,
before 1995 only inpatients were registered. In child-
and adolescent psychiatry, in-patient admissions
refer to overnight stays as well as daily hospital visits
over an extended period. Our study covers nearly all
schizophrenia diagnoses as schizophrenia is a severe
mental illness, which is most often cared for in an in-
patient hospital setting, as defined above (24). Few
private clinics and no private hospitals with over-
night inpatient facilities were available during the
study period (26). The DCPRR covers the entire
Danish population, that is, both those born in the
country and immigrants.
The study population consisted of all patients
diagnosed with an ICD-8 schizophrenia diagnosis
(295) before the age of 18 in the period from 1971
throughout 1993 or an ICD-10 schizophrenia
diagnosis (F20) in the period from 1994 through-
out 2010. The ICD-9 was not introduced in
Denmark. To examine the relative proportions of
schizophrenia vs all psychiatric diagnoses, we used
ICD-8 diagnoses (290–315) in the period 1971
throughout 1993 or ICD-10 diagnoses (F00–F99)
in the period 1994 throughout 2010. As to inves-
tigate the incidence of schizophrenia, only the first
schizophrenia diagnosis in the DCPRR was
utilized. Cases were not followed in the registries
for subsequent diagnoses.
Diagnoses registered from emergency room
visits were excluded as no investigation of the
validity of these diagnoses have been conducted,
and the validity is considered low if no in- or
outpatient treatment has occurred. Prescription
data were not used to validate case diagnosis, as
data were not available for the entire study period.
Statistical analysis
Descriptive analyses were performed using the
Student¢s T-test, Z-test, and two-sample test of
proportions.
Age standardization of data was performed to
account for changes in the age composition of
the population during the study period. The
principle is to apply the age-specific incidence
rates from each year of our study population to the
age distribution of a standard population. WHO
recommends basing the standardization on the
average age composition of the populations com-
pared in the period (27, 28). Data on the age
composition of the Danish population are avail-
able through Statistics Denmark.
Incidence rates (IR) were calculated as the number
of incident cases divided by the total number of
people in the population of same age that year. As
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the average population size per year is approxi-
mately equal to person-time, we have used the term
per 100 000 person years. Incidence rates were
age-standardized as described previously.
Incidence rate ratios (IRR) were calculated for
different time periods as the IR of EOS divided by
all IR of all psychiatric cases.
All calculations of IR and IRRs were repeated
with data stratified by sex. Statistical analyses were
performed with STATA (29).
To reduce the risk of Type I errors, a correction
was applied to the standard p-value of 0.05, and
P < 0.01 was selected as a reasonable significance
criterion.
The data were provided at the group level and
anonymously, in keeping with guidelines for
epidemiological research required by the Danish
Data Protection Agency and the National Board of
Health. No ethical research committee approval
was needed, as data were obtained from registers
for statistical purposes only.
Results
A total of 1536 persons diagnosed with schizophre-
nia before the age of 18 years between 1971 and
2010 were identified in the DPCRR. Of these, 54%
were men (male ⁄ female ratio = 1.2 : 1)
(P < 0.001). The mean age at diagnosis was 15.8,
median 16.0, interquartile range (IQR)
15.7–16.1 years, with men (mean 15.8, median
15.8, IQR 15.6–16.2) and women (mean 15.8,
median 15.8, IQR 15.6–16.2) being diagnosed at
the same age in the entire study period (P > 0.999).
A total of 517 persons were diagnosed in the time
period 1971–1993 (ICD-8), with 65%men and 35%
women (P < 0.001). Mean age at diagnosis was
16.1, median 16.1, IQR 15.8–16.3 years, with men
(mean 16.0, median 15.9, IQR 15.8–16.3) and
women (mean 16.3, median 16.3, IQR 16.0–16.4)
being diagnosed at the same age (P = 0.347). A
total of 1019 persons were diagnosed between 1994
and 2010 (ICD-10), with 48% men and 52%
women (P = 0.071). The mean age at diagnosis
was 15.7, median 15.7, IQR 15.6–16.0 years, with
no significant age difference between men (mean
15.7, median 15.7 years, IQR 15.5–16.0) and
women (mean 15.7, median 15.7, IQR 15.5–16.0),
P > 0.999. The mean age at diagnosis was signif-
icantly higher for patients diagnosed in the period
1971–1993 compared to 1994–2010, P < 0.001.
Changes in sex distribution of schizophrenia
diagnosis over time is presented in Fig. 1.
The mean age-standardized IR of EOS from
1971 to 2010 was 3.17 (95% CI: 3.16, 3.18) per
100 000 person years. The mean age-standardized
IR of EOS from 1971 to 1993 was 1.80 (95% CI:
1.79, 1.82) per 100 000 person years and the mean
age-standardized IR of EOS from 1994 to 2010 was
5.15 (95% CI: 5.10, 5.20) per 100 000 person years.
Comparing the two time periods, the difference was
3.34 (95% CI: 3.29, 3.40). Age at diagnosis for each
sex is presented in Fig. 2.
The mean age-standardized IR of EOS in the
age group 12 to 18 years of age from 1971 to
2010 was 9.10 (95% CI: 9.00, 9.21) per 100 000
person years. The mean age-standardized IR of
EOS in the age group 12 to 18 years of age from
1971 to 1993 was 5.02 (95% CI: 4.92, 5.11) per
100 000 person years compared with 15.73 (95%
CI: 15.22, 16.22) per 100 000 person years in the
period 1994 to 2010. Comparing the two time
periods, the difference was 10.72 (95% CI: 10.22,
11.21). Data on IR are presented in Table 1.
The age-standardized IRR, i.e. the proportion
of EOS diagnoses of all psychiatric child and
adolescent diagnoses, from 1971 to 2010, was
0.016 (95% CI: 0.015, 0.017). Men had a signif-
icantly lower IRR than women, diff = 0.002
(95% CI: 0.002, 0.002). The age-standardized
IRR from 1971 to 1993 was 0.034 (95% CI:
0.031, 0.037). Men had a significantly higher IRR
than women, diff = 0.013 (95% CI: 0.011, 0.015).
The age-standardized IRR between EOS and all
psychiatric diagnoses from 1994 to 2010 was 0.013
(95% CI: 0.012, 0.014). Men had a significantly
lower IRR than women, diff = 0.005 (95% CI:
0.004, 0.005). The IRRs were significantly higher
for patients diagnosed in the period 1971–1993
compared to 1994–2010, diff = 0.021 (95% CI:
0.019, 0.024). This was also true for men
(diff = 0.029, P < 0.001) and women
(diff = 0.012, P < 0.001) divided.
Discussion
Wefound that the overall IRofEOSwas lower in the
period 1971–1993 compared to 1994–2010 both for
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Fig. 1. Changes in sex distribution of schizophrenia diagnosis
over time.
Okkels et al.
64
Ta
bl
e
1.
Ch
an
ge
s
in
de
m
og
ra
ph
y
an
d
in
ci
de
nc
e
ra
te
s
of
sc
hi
zo
ph
re
ni
a
an
d
al
lp
sy
ch
ia
tri
c
di
ag
no
si
s
be
fo
re
th
e
ag
e
of
18
ye
ar
s
Pe
rio
d
In
ci
de
nc
e
ra
te
0–
18
ye
ar
s
(p
er
10
0
00
0
pe
rs
on
ye
ar
s)
Co
un
t
of
ca
se
s
(0
–1
8
ye
ar
s)
Ag
e
at
di
ag
no
si
s
Sx
IR
(9
5%
CI
)
Sx
IR
(m
al
e)
(9
5%
CI
)
Sx
IR
(fe
m
al
e)
(9
5%
CI
)
P
(m
al
e–
fe
m
al
e)
n s
x
(m
al
e)
n a
ll
(m
al
e)
n s
x
(fe
m
al
e)
n a
ll
(fe
m
al
e)
P s
x
(m
al
e–
fe
m
al
e)
Ag
e S
x,
m
ea
n;
m
ed
ia
n
(IQ
R)
Ag
e S
x
m
al
e,
M
ea
n;
M
ed
ia
n
(IQ
R)
Ag
e S
x
fe
m
al
e,
M
ea
n;
M
ed
ia
n
(IQ
R)
P
(m
al
e–
fe
m
al
e)
19
71
–2
01
0
3.
17
(3
.1
6–
3.
18
)
3.
34
(3
.3
1–
3.
37
)
2.
99
(2
.9
6–
3.
01
)
<0
.0
01
82
9
(5
4%
)2
4.
81
5.
79
9
70
7
(4
6%
)2
3.
64
9.
07
3
<0
.0
01
15
.8
;1
6.
0
(1
5.
7–
16
.1
)
15
.8
;1
5.
8
(1
5.
6–
16
.2
)1
5.
8;
15
.8
(1
5.
6–
16
.2
)
>
0.
99
9
19
71
–1
99
3
1.
80
(1
.7
9–
1.
82
)
2.
28
(2
.2
5–
2.
31
)
1.
30
(1
.2
8–
1.
32
)
<0
.0
01
33
5
(6
5%
)1
4.
66
9.
99
5
18
2
(3
5%
)1
3.
99
8.
22
6
<0
.0
01
16
.1
;1
6.
1
(1
5.
9–
16
.3
)
16
.0
;1
5.
9
(1
5.
8–
16
.3
)1
6.
3;
16
.3
(1
6.
0–
16
.4
)
0.
34
7
19
94
–2
01
0
5.
15
(5
.1
0–
5.
20
)
4.
87
(4
.7
8–
4.
96
)
5.
44
(5
.3
3–
5.
55
)
<0
.0
01
49
4
(4
8%
)1
0.
14
5.
80
4
52
5
(5
2%
)
9.
65
0.
84
7
0.
07
1
15
.7
;1
5.
7
(1
5.
6–
16
.0
)
15
.7
;1
5.
7
(1
5.
5–
16
.0
)1
5.
7;
15
.7
(1
5.
5–
16
.0
)
>
0.
99
9
Pe
rio
d
In
ci
de
nc
e
ra
te
12
–1
8
ye
ar
s
(p
er
10
0
00
0
pe
rs
on
ye
ar
s)
Co
un
t
of
ca
se
s
(1
2–
18
ye
ar
s)
Sx
IR
(9
5%
CI
)
Sx
IR
(m
al
e)
(9
5%
CI
)
Sx
IR
(fe
m
al
e)
(9
5%
CI
)
P
(m
al
e–
fe
m
al
e)
n s
x
(m
al
e)
n a
ll
(m
al
e)
n s
x
(fe
m
al
e)
n a
ll
(fe
m
al
e)
P s
x
(m
al
e–
fe
m
al
e)
19
71
–2
01
0
9.
10
(9
.0
0–
9.
21
)
9.
52
(9
.3
0–
9.
74
)
8.
66
(8
.4
5–
8.
87
)
<0
.0
01
81
1
(5
4%
)
8.
51
6.
36
5
70
3
(4
6%
)
8.
11
6.
52
0
<0
.0
01
19
71
–1
99
3
5.
02
(4
.9
2–
5.
11
)
6.
34
(6
.1
1–
6.
58
)
3.
62
(3
.4
8–
3.
76
)
<0
.0
01
33
4
(6
5%
)
5.
26
6.
58
4
18
2
(3
5%
)
5.
02
2.
82
5
<0
.0
01
19
94
–2
01
0
15
.7
3
(1
5.
22
–1
6.
22
)
14
.6
8
(1
3.
79
–1
5.
56
)
16
.8
4
(1
5.
78
–1
7.
91
)
<0
.0
01
47
7
(4
8%
)
3.
24
9.
78
1
52
1
(5
2%
)
3.
09
3.
69
5
0.
07
4
IR
R S
x
⁄A
ll
(9
5%
CI
)
IR
R S
x
⁄A
ll
(m
al
e)
(9
5%
CI
)I
RR
Sx
⁄A
ll
(fe
m
al
e)
(9
5%
CI
)P
(m
al
e–
fe
m
al
e)
19
71
–2
01
0
0.
01
6
(0
.0
15
–0
.0
17
)
0.
01
5
(0
.0
14
–0
.0
16
)
0.
01
7
(0
.0
16
–0
.0
19
)
<0
.0
01
19
71
–1
99
3
0.
03
4
(0
.0
31
–0
.0
37
)
0.
04
0
(0
.0
36
–0
.0
40
)
0.
02
7
(0
.0
23
–0
.0
31
)
<0
.0
01
19
94
–2
01
0
0.
01
3
(0
.0
12
–0
.0
14
)
0.
01
1
(0
.0
10
–0
.0
12
)
0.
01
5
(0
.0
14
–0
.0
17
)
<0
.0
01
IR
,i
nc
id
en
ce
ra
te
;I
RR
,i
nc
id
en
ce
ra
te
ra
tio
;I
QR
,I
nt
er
qu
ar
til
e
ra
ng
e
(2
5–
75
%
pe
rc
en
til
e)
.
Incidence of early onset schizophrenia
65
men and women in the age groups 0–18 years and
12–18 years. The latter age group was computed
because the main portion of incident EOS is within
this age group. To our knowledge, there exist no
clear consensus on what age the risk of schizo-
phrenia begins, i.e. which age group should be used
for calculationof IR inEOS. In the period from1971
to 1993, men had a significantly higher IR of EOS
than women, contrary to 1994–2010 where women
had a significantly higher IR of EOS than men.
Finally, EOS patients were diagnosed at a signifi-
cantly lower age in the period 1994–2010 compared
to 1971–1993, but this difference was not significant
when divided into men and women.
The IRRs show that EOS made up a larger
proportion of all diagnoses in the time period
1971–1993 compared to 1994–2010, both for men
and women. A similar change in age-specific
first-admission rates for schizophrenia and other
psychotic disorders is reported in Canton Zurich,
Switzerland, in the age group 15–19 years (30).
There are several possible explanations for the
changes in incidence of EOS and all psychiatric
diagnoses. From 1970 to 1990, a change in organi-
zational structure of treatment facilities took place
(15). In adult psychiatry, the number of psychiatric
beds was reduced by 50% from mid 1970s to
1990 without sufficient supplementary extension
of community psychiatric service or any other in- or
outpatient treatment facility (17), thus decreasing or
delaying the possibility of getting a psychiatric
evaluation. Child and adolescent psychiatry as a
psychiatric specialitywas established in 1994. Before
this, child psychiatry did not routinely include
treatment of adolescents, which took place in both
adult and child psychiatric wards, depending on the
hospital. Data from The National Board of Health
show a decrease of 33% in beds allocated to children
and adolescents from 1980 to 1986, but by 1995, the
number resembles that from 1980. Since 1990 the
number of beds in child and adolescent psychiatry
has increased. Thus, a decrease in the number of
psychiatric beds could lead to a decrease in the
number of psychiatric diagnoses. A study from
Finland found a decrease in incidence of schizo-
phrenia after a decrease in psychiatric beds (22).
A similar decrease in incidence was found in a
Danish survey from 1987 (16), examining first-
admission adult patients to psychiatric institutions
1970–1980. One explanation proposed was an
increased use of differential diagnosis as first-
admission diagnosis for patients later to be diag-
nosed with schizophrenia, i.e. a tendency to avoid
the diagnosis of schizophrenia. Other studies uti-
lizing data from DCPRR have shown a tendency
to withhold the schizophrenia diagnosis until
patients had been ill for a longer time period,
with negative symptoms, and with a confirmed
poor prognosis (31). The delay in diagnosis could
be even more prolonged in child and adolescent
psychiatry because of the rarity of the disorder,
resulting in a proportion of patients passing the age
of 18 years, thereby causing a lower incidence of
EOS. This explanation is supported by the higher
average age at EOS diagnosis in the time period
1971–1993 compared to 1994–2010, suggesting a
possible delay in diagnosis in the former compared
to the latter. The greater focus on psychosis and
psychosis risk could have caused the decline in age
at schizophrenia diagnosis (32, 33).
In Denmark, the ICD-10 replaced the ICD-8 in
1994. No studies of ICD-8 to ICD-10 reliability of
EOS have been conducted. A single study of case
vignettes on adult psychiatric diagnoses from
ICD-8 to ICD-10 reported no reliability problems
regarding the schizophrenia diagnosis (34).
The incidence of EOS is higher in the period
1994–2010 compared to 1971–1993. It is possible
that the ICD change induced a surge of re-
diagnosing patients from one category to another,
predominantly toward schizophrenia. If this is
true, part of the increase in incidence is caused by
bias in monitoring, although re-diagnosis in child
and adolescent psychiatry is probably minor
compared with adult psychiatry. Tsuchiya and
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Fig. 2. Crude incidence rates at age of diagnosis.
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Munk-Jorgensen have argued against the ICD
change as an explanation (15). In 2002, they
documented that the increase in incidence of
adult schizophrenia started before the replacement
of ICD-8 by ICD-10 (15).
Men were predominately diagnosed with EOS
throughout the study, 1971–2010, but the male to
female ratio changed during the two study periods,
with a clear male dominance in the 1971–1993 ratio.
In contrast, there was no difference between the
sexes in the period 1994–2010. The equilibrium
between number of male and female patients in
1994–2010 is in contrast to the male dominance in
adult schizophrenia diagnosis (35). No larger epi-
demiological studies of schizophrenia diagnosis
before the age of 18 years have been performed,
and therefore, no reports ofmale to female ratios are
available for comparison. The other large Danish
register study of EOS includes patients up to 21
years of age and shows similar results of no
difference in male to female ratios before the age
of 18 years, but with a greater proportion of males
diagnosed after the age of 18 years (3).
Table 1 shows that the incidence of schizophre-
nia and all psychiatric diagnoses does not increase
proportionally. This trend is markedly more
evident for men compared with women. Overall,
the changes in IRR could perhaps be attributed to
more focus on child and adolescent psychiatric
disorders. For example, the introduction of Asper-
gers syndrome and modification of the criteria of
hyperkinetic disorder in ICD-10 in 1994 in Den-
mark, could have caused the more severe disorders,
such as schizophrenia, to be diagnosed propor-
tionally less often (36). Of great importance related
to the proportion of EOS is the inclusion of
outpatient incident diagnoses from 1995 in
DPCRR. This might have caused a slight increas-
ing IR of EOS, but has the greatest effect on
disorders commonly treated on outpatient basis.
It has been suggested that cannabis misuse
(37–40) and changes in misuse patterns during
the last decades (41) could affect incidence of
schizophrenia. The change in misuse of cannabis
could perhaps explain the lower age at diagnosis in
1994–2010. However, data on misuse would sug-
gest men being diagnosed earlier than women (42),
but this was not implied in our findings.
Lastly, actual fluctuations in the relative number
of patients developing schizophrenia or other
psychiatric disorders before the age of 18 years
within the four decades investigated in the study
could be a possible explanation for our findings.
The study has some important limitations. (i) The
validity of the EOS diagnosis has not been examined
in theDPCRR, neither has the reliability of the EOS
diagnosis from ICD-8 to ICD-10. (ii) All reported
incidences are solely diagnosed incidences, thus
individuals without contact to the psychiatric
system were not included. Schizophrenia is a severe
mental illness, which is most often cared for in an
inpatient hospital setting, but patients diagnosed
solely as outpatients before 1995, are not in the
register. (iii) In calculating IR, we used the number
of persons in eachage group for each timeperiod as a
proxy of person-time, as data on date of diagnosis
and date of birthday were unavailable.
In conclusion, we found a general increase in
schizophrenia and all psychiatric disorders diag-
nosed before the age of 18 years over the study
period of four decades. There was a change in sex
distribution of EOS from an initial male domi-
nance to an even distribution. The increase was
probably caused by a combination of factors, for
example, changes in diagnostic system, changes in
organizational structure, drug abuse or more focus
on child and adolescent psychiatric disorders in
diagnostic practice. Last, but not least, our findings
could be explained by a true increase in the number
of persons developing psychiatric disorders.
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